<h1 id="transient-ischemic-attack-tia-">Transient Ischemic Attack (TIA)</h1>
<p><strong>TIA Definition</strong></p>
<ul>
<li>Focal neuro deficit from brain/retina ischemia &lt; 24 hrs (although most &lt; 1 hr) </li>
</ul>
<p><strong>2002 TIA Working Group Definition of TIA</strong></p>
<ul>
<li>&quot;Brief episode of neuro dysfunction caused by focal brain or retinal ischemia, with clinical symptom typically lasting &lt; 1 hr, and with evidence of acute infarct&quot; (has CT criteria)</li>
</ul>
<h2 id="tia-progression-to-cva">TIA Progression to CVA</h2>
<ul>
<li><strong>Kaiser study:</strong> 5% in 48 hrs, 10.5% in 90 days (JAMA, 2000)</li>
<li><strong>Oxfordshire study:</strong> 8% in 7d, 11.5% in 1 mo, 17.3% in 3 mo</li>
<li><strong>Canadian stroke registry:</strong> 4% in 48 hrs, 8% in 30 days</li>
</ul>
<h2 id="validated-risk-stratification-scoring-tools">Validated Risk Stratification Scoring Tools</h2>
<p><strong>California score</strong></p>
<p>1707 HMO pts - cohort analysis. High risk CVA predictors (max of 5 pts):1. Age &gt; 60 (OR 1.8)
Sx of weakness (OR 1.9)
Sx of speech impairment, incl dysarthria or aphasia (OR 1.5)
DM (OR 2.0)
Sx duration &gt; 10 min (OR 2.3)</p>
<ul>
<li>If 0 points --&gt; 0% CVA&#39;s in 90 days. If 5 points --&gt; 34% CVA&#39;s in 90 days(about half of those in 48 hrs!) </li>
</ul>
<p><strong>ABCD score</strong>
Cohort study 209 pts, validated on 190 pts, tested for clinicalutility on 588 pts. Independent predictors for CVA in 7 days (max of 6 points):</p>
<ul>
<li>Age &gt; 60 (HR 2.6)</li>
<li>Blood pressure - HTN (SBP &gt; 140 or DBP &gt; 90) (HR 9.7)</li>
<li>Clinical features of unilateral weakness (HR 6.6)</li>
<li>Clinical feature of speech disturbance w/o weakness (HR 2.6)</li>
<li>Duration of Sx &lt; 10 min (HR 1.0) - 0 pts, 10-60 min (HR 3.1) - 1 pt, &gt; 60 min (HR 6.2) - 2 pts</li>
<li>If ABCD score â‰¤ 3, then 0% CVA in 7 days</li>
<li>If ABCD score &gt; 3, then increased risk 2.2% (4 pt), 16.3% (5 pt), 35.5% (6 pt) </li>
</ul>
<p><strong>Combined ABCD2 score</strong></p>
<ul>
<li>1916 cohort patients, validation in 2893 patients. Isessentially the ABCD score PLUS hx of DM (1 point) for max of 7 points [Johnston etal, Lancet, 2007]</li>
<li>0-3 points (low risk): 1, 1.2, 3.1% risk of CVA in 2, 7, 90 days </li>
<li>4-5 points (mod risk): 4.1, 5.9, 9.8% risk</li>
<li>6-7 points (high risk): 8.1, 11.7, 17.8% risk </li>
</ul>
<h2 id="imaging">Imaging</h2>
<p><strong>MRI for TIA</strong></p>
<ul>
<li>A positive DWI lesion correlates with higher risk for subsequent CVA </li>
</ul>
<p><strong>Carotid imaging</strong></p>
<ul>
<li>Large-vessel TIA is assoc with higher short-term CVA risk</li>
</ul>
<p><strong>Echocardiography</strong></p>
<ul>
<li>Especially important in younger patients without large vessel cause to detect atrial/ intraventricular intramural clot, or valvular dz prone to emboli, or patent foramen ovale with hypercoag disorder.</li>
</ul>
<h2 id="inpatient-vs-outpatient-evaluation-of-tia">Inpatient vs Outpatient Evaluation of TIA</h2>
<p>Unclear benefit of expedited inpatient workup based on CVA incidence in inpt vs outpt
National Stroke Association TIA guideline (2006):</p>
<ul>
<li>Hospitalization &quot;considered&quot; for a first TIA in the past 24-48 hrs </li>
<li>Hospitalization &quot;generally recommended&quot; for patients with crescendo TIA, duration &gt; 1 hr, symptomatic carotid stenosis &gt; 50%, known cardiac embolic source, hypercoag state, or ABCD2 score </li>
</ul>
<!-- -->
<h2 id="tia-management">TIA Management</h2>
<p>Although most studies of treatment in CVA (not TIA): </p>
<p><strong>Head of bed flat</strong>
<strong>&quot;Permissive hypertension&quot;</strong>: Because of impaired cerebral autoregulation: Allow HTN until SBP &gt; 220 or DBP &gt; 120
<strong>IVF administration</strong>
<strong>Antiplatelet Treatment</strong></p>
<ul>
<li>Reduces risk for CVA, AMI, Vascular death by 20% with recent TIA. </li>
<li>High dose ASA is NOT more effective: <strong>50-75 mg ASA</strong> is sufficient.</li>
<li>Unclear benefit of clopidogrel.</li>
</ul>
<p><strong>Statins</strong>: Reduces 1-yr risk for recurrent vascular events in TIA / CVA patients </p>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19218019">Ross M, Nahab F. Management of transient ischemia attacks in the twenty-first century. Emerg Med Clin North Am. 2009 Feb;27(1):51-69, viii.</a></li>
</ul>
